[减少或不减少阿片类药物 - - 这是问题]
Emmanuel Bäckryd1, Paulin Andréll2, Marcelo Rivano Fischer3
1bitr -professor, över-läkare, Linköpings -universitet.
概括
长期使用阿片类药物治疗慢性非癌症疼痛缺乏证据,欧洲指导方针也不建议使用阿片类药物. 持续评估和早期停药至关重要,以防止不良结果,并谨慎考虑逐渐减少.
科学领域:
- 治疗疼痛
- 药理学
- 公共卫生
背景情况:
- 有限的证据支持长期阿片类药物治疗慢性非癌症疼痛.
- 欧洲的指导方针建议不要使用阿片类药物治疗原发性慢性疼痛.
- 持续评估阿片类药物的益处和危害至关重要.
研究的目的:
- 强调长期阿片类药物治疗慢性非癌症疼痛的复杂性.
- 强调考虑逐渐减少阿片类药物的重要性 (停止处方).
- 概述与阿片类药物逐渐减少相关的潜在益处和风险.
主要方法:
- 对长期使用阿片类药物的当前指导方针和临床考虑的审查.
- 讨论逐渐减少的过程,包括计划支持和后续行动.
- 分析潜在的益处 (安全性,副作用逆转) 和风险 (戒断,心理健康).
主要成果:
- 这是一种复杂的医疗干预,
- 逐渐减少的风险包括戒断症状,疼痛恶化和心理健康问题.
- 在这一患者群体中,有问题的阿片类药物使用和阿片类药物使用障碍是令人担忧的.
结论:
- 需要仔细规划,支持和密切监控.
- 处方者应避免对有问题的阿片类药物使用患者的歧视态度.
- 应考虑及早停止使用阿片类药物,以防止负面的健康状况.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
326
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
326


